The HepQuant SHUNT Test for Monitoring Liver Disease and Treatment Effects by Measuring Liver Function and Physiology
Sponsor: HepQuant, LLC
Terminated
Primary study stopped early
Other NASH - Nonalcoholic Steatohepatitis trials with similar outcome
Listed as NCT03294941, this PHASE2 trial focuses on NASH - Nonalcoholic Steatohepatitis and remains terminated or withdrawn. Sponsored by HepQuant, LLC, it has been updated 9 times since 2017, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Sep 2021 — Jul 2024 [monthly]
Terminated PHASE2
Status: Active Not Recruiting → Terminated
-
Jan 2021 — Sep 2021 [monthly]
Active Not Recruiting PHASE2
-
Feb 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE2
▶ Show 4 earlier versions
-
Sep 2019 — Feb 2020 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Sep 2019 [monthly]
Recruiting PHASE2
-
Feb 2018 — Jun 2018 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Oct 2017 — Feb 2018 [monthly]
Not Yet Recruiting PHASE2
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- HepQuant, LLC
For direct contact, visit the study record on ClinicalTrials.gov .